Novozymes buys Irish probiotic maker PrecisionBiotics

Danish enzyme maker Novozymes will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics company in recent years as it seeks to grow its human health business. "The presence that we have today in human health is small, and this is why we are coming with an acquisition to get the critical mass, to drive the momentum," newly appointed chief executive Ester Baiget told Reuters. Baiget, who took over the helm of Novozymes in February, said the main focus was on growth, both in the top line and profitability..
Danish enzyme maker Novozymes will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics company in recent years as it seeks to grow its human health business. The presence that we have today in human health is small, and this is why we are coming with an acquisition to get the critical mass, to drive the momentum, newly appointed chief executive Ester Baiget told Reuters. Baiget, who took over the helm of Novozymes in February, said the main focus was on growth, both in the top line and profitability..
Danish enzyme maker Novozymes will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics

Lactase Market Size, Share & Outlook Trends to 2022-2028

Renatus Weekly M&A and Company Performance Newsletter - 28/06/2020

Novozymes OneHealth builds on parent company's strategic vision

Novozymes Food Business Africa Magazine

Novozymes buys Irish probiotic maker PrecisionBiotics

About Novozymes.

Novozymes acquires PrecisionBiotics

PDF) An Exopolysaccharide Produced by Bifidobacterium longum 35624

2020 University College Cork

Immune by PrecisionBiotics - Unique Bifidobacterium Longum Strain

Home - PrecisionBiotics

Novozymes - Recent News & Activity

Novozymes acquires data science platform of Biota to strengthen

EC review of Novozymes and Chr. Hansen tie-up likely time